- Home
- TNYA
as of 12-09-2025 3:46pm EST
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 234.8M | IPO Year: | 2021 |
| Target Price: | $8.60 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.36 - $4.01 | Next Earning Date: | 11-10-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered TNYA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Tenaya Therapeutics Inc. (TNYA)
Chief Medical Officer
Avg Cost/Share
$1.33
Shares
2,877
Total Value
$3,826.41
Owned After
169,926
SEC Form 4
SVP, Finance
Avg Cost/Share
$1.33
Shares
1,367
Total Value
$1,818.11
Owned After
93,971
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Tingley Whittemore | TNYA | Chief Medical Officer | Nov 17, 2025 | Sell | $1.33 | 2,877 | $3,826.41 | 169,926 | |
| Ali Faraz | TNYA | Chief Executive Officer | Nov 17, 2025 | Sell | $1.33 | 3,126 | $4,157.58 | 299,666 | |
| Higa Tomohiro | TNYA | SVP, Finance | Nov 17, 2025 | Sell | $1.33 | 1,367 | $1,818.11 | 93,971 |
Compare TNYA vs Leading Stocks
See how TNYA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TNYA Tenaya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.